Eli Lilly, the maker of blockbuster weight loss and diabetes drugs Zepbound and Mounjaro, said it will invest an additional ...
Over the last few years, as Eli Lilly has revealed a series of manufacturing investments—each one seemingly more lavish than ...
Eli Lilly said it will invest at least $27 billion to build four new manufacturing sites in the U.S. as demand for its weight ...
The latest weight-loss drugs including Ozempic, Wegovy, Mounjaro, and Zepbound have list prices ranging from $900 to $1,500 for a one-month supply. David Ricks, the CEO of Mounjaro and ...
Eli Lilly is unleashing new ammunition in its fight against cheaper, compounded versions of its obesity blockbuster Zepbound.
The program includes a 30-minute video chat with a licensed and board certified doctor who can write you a prescription for Mounjaro if appropriate. Ro offers Zepbound, which contains the same ...
The update about the popular semaglutide injections from drug manufacturer Novo Nordisk follows just two months after the FDA said that shortages of tirzepatide injections Zepbound and Mounjaro ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback